Modicus Prime, an Austin, Texas-based provider of an AI compliance platform for audit-ready AI systems in the pharmaceutical industry, has raised $4.5 million in funding.
Investors
The funding round was led by Frist Cressey Ventures, with additional backing from Silverton Partners and Oncology Ventures, bringing Modicus Prime's total funding to $8 million.
Frist Cressey Ventures (FCV) is a healthcare venture capital firm with $846 million in assets under management (AUM), focused on accelerating the growth of high-potential healthcare companies through a differentiated healthcare network, hands-on leadership support, and healthcare policy expertise. Its mission is to transform healthcare and improve lives. FCV’s strategic partners, including The Cigna Group, MedStar Health, and OhioHealth, provide healthcare services to more than 50% of the U.S. population. Frist Cressey Ventures invests in early-stage startups that build technology or tech-enabled services to advance quality of care, system integration, patient outcomes, affordability, and access.
Modicus Prime Use of Funds
The company will use the new capital to expand customer support capabilities and enhance its platform to support growing AI compliance and deployment needs for pharmaceutical customers globally.
About Modicus Prime
Modicus Prime is a healthcare technology company focused on enabling compliant and scalable AI adoption in regulated pharmaceutical environments. The company provides an AI compliance platform that bridges data science, IT, and quality functions, enabling regulated organizations to deploy and scale trustworthy AI. It integrates with pharmaceutical technology stacks and quality management systems to provide audit-ready AI governance across the full AI lifecycle. Its platform supports pharmaceutical companies, CROs, CMOs, and CDMOs by helping ensure compliance with global regulators such as the FDA and EMA.
Funding Details
Company: Modicus Prime Limited
Raised: $8.0M
Round: Unknown
Funding Date: May 2026
Lead Investor: Frist Cressey Ventures
Additional Investors: Silverton Partners and Oncology Ventures
Company Website: https://www.modicusprime.com/
Software Category: AI Compliance Software
Source: https://www.prnewswire.com/news-releases/modicus-prime-raises-8m-to-enable-ai-audit-readiness-across-pharma-302763769.html